May is Melanoma/Skin Cancer Detection and Prevention Month – the perfect time, as we head into summer, to think about protecting our skin. The American Cancer Society predicts that in 2019, almost 100,000 American adults will be diagnosed with invasive melanoma, and while that number may not be massive, it’s important, as melanoma is the deadliest of the skin cancers. Treatments are often ineffective; thus, early intervention is crucial.
Meet physicist Prof. Erez Berg, the 2019 Physical Sciences & Engineering Laureate of the Blavatnik Awards for Young Scientists. Prof. Berg has conducted influential studies to gain insights into quantum materials—materials whose electronic properties cannot be characterized by traditional physics. His research holds major promise for devising new ways of storing and manipulating quantum information, with implications for a new computing age, as well as next-generation electronics, superconducting power lines, and MRI technologies. The Blavatnik Awards, presented by The Blavatnik Family Foundation, the New York Academy of Sciences, and the Israel Academy of Sciences and Humanities (IASH), recognize early-career scientists and engineers in Israel for both their extraordinary achievements and promise for future discoveries. Of the three 2019 laureates, two were from the Weizmann Institute; the other Weizmann winner was Dr. Michal Rivlin of the Department of Neurobiology. Video courtesy of the New York Academy of Sciences.
Meet visual neuroscientist Dr. Michal Rivlin, the 2019 Life Sciences Laureate of the Blavatnik Awards for Young Scientists. Dr. Rivlin’s research is making major strides in understanding sight, in particular the retina, the part of the eye where all visual processes begin. She has found that retinal cells, rather than being fixed and hardwired, are malleable and can dramatically change their properties in response to stimuli like light and motion. Her work has implications for retinal disease and blindness, and the development of computer vision technologies. The Blavatnik Awards, presented by The Blavatnik Family Foundation, the New York Academy of Sciences, and the Israel Academy of Sciences and Humanities (IASH), recognize early-career scientists and engineers in Israel for both their extraordinary achievements and promise for future discoveries. Of the three 2019 laureates, two were from the Weizmann Institute; the other Weizmann winner was Prof. Erez Berg of the Department of Condensed Matter Physics. Video courtesy of the New York Academy of Sciences.
Thanks to the quality of its science and healthcare, Israel is becoming a world leader in the aging industry, says Israel21C. Two of the reasons for this: Weizmann’s Profs. Valery Krizhanovsky and Michal Schwartz.
May 01, 2019
Steba Biotech, a privately owned company, has, in collaboration with scientists at the Weizmann Institute of Science, conducted extensive research and development on the prostate cancer treatment TOOKAD® – and now has received marketing authorization to make it available in 31 European countries. Following this regulatory approval, the first patients are currently being treated in top Israeli, German, English, and Italian medical centers.
April 29, 2019
Parkinson’s News Today discusses the research of Prof. Tamar Flash, who uses artificial intelligence – and takes inspiration from the octopus – to find ways to aid people with the disease.
April 23, 2019
There is a reason that a puzzle piece is the symbol of autism spectrum disorder (ASD). Despite all the research, despite the advances, ASD continues to be an enigma. What causes it? Can it be diagnosed earlier? What are the differences between an autistic and a neurotypical brain?
One field of research – the role of the sense of smell – is producing surprising results that could lead to means of early diagnosis and intervention, as well as shed light on the misreading of social cues that is so common in autism.
As The Daily Mail reports, Dr. Gad Asher and colleagues in California have found that exercising at the end of the day can provide up to 50% better performance.
April 18, 2019
Issue 52 of Weizmann Views presents the research of Prof. Michal Schwartz, who pioneered the field of neuroimmunity. She is working on methods for treating Alzheimer’s and other age-related diseases.
©2019 American Committee for the Weizmann Institute of Science
